{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:59:52Z","timestamp":1792807192262,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["03-2015-0120"],"award-info":[{"award-number":["03-2015-0120"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A2B4009438"],"award-info":[{"award-number":["2016R1A2B4009438"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Boramae Hospital","doi-asserted-by":"crossref","award":["03-2013-8 and 01-2014-11"],"award-info":[{"award-number":["03-2013-8 and 01-2014-11"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2017R1A2B3006704 and 2019R1A6A1A03032869"],"award-info":[{"award-number":["2017R1A2B3006704 and 2019R1A6A1A03032869"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The search for noninvasive biomarkers of neuroinflammation and neurodegeneration has focused on various neurological disorders, including epilepsy. We sought to determine whether \u03b1-synuclein and cytokines are correlated with the degree of neuroinflammation and\/or neurodegeneration in children with epilepsy and with acquired demyelinating disorders of the central nervous system (CNS), as a prototype of autoimmune neuroinflammatory disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed serum and exosome levels of \u03b1-synuclein and serum proinflammatory and anti-inflammatory cytokines among 115 children with epilepsy and 10 acquired demyelinating disorders of the CNS and compared to 146 controls. Patients were enrolled prospectively and blood was obtained from patients within 48\u2009h after acute afebrile seizure attacks or relapse of neurological symptoms. Acquired demyelinating disorders of the CNS include acute disseminated encephalomyelitis, multiple sclerosis, neuromyelitis optica spectrum disorders, and transverse myelitis. The controls were healthy age-matched children. The serum exosomes were extracted with ExoQuick exosome precipitation solution. Serum \u03b1-synuclein levels and serum levels of cytokines including IFN-\u03b2, IFN-\u03b3, IL-1\u03b2, IL-6, IL-10 and TNF-\u03b1 were measured using single and multiplex ELISA kits. Data were analyzed and compared with measures of disease severity, such as age at disease onset, duration of disease, and numbers of antiepileptic drug in use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Serum \u03b1-synuclein levels were significantly increased in patients with epilepsy and acquired demyelinating disorders of the CNS compared to controls (both,<jats:italic>p\u2009&lt;\u20090.<\/jats:italic>05) and showed correlation with measures of disease severity both in epilepsy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05,<jats:italic>r<\/jats:italic>\u2009=\u20090.2132) and in acquired demyelinating disorders of the CNS (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05,<jats:italic>r<\/jats:italic>\u2009=\u20090.5892). Exosome \u03b1-synuclein showed a significant correlation with serum \u03b1-synuclein (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001,<jats:italic>r<\/jats:italic>\u2009=\u20090.5915). Serum IL-1\u03b2 levels were correlated only with the numbers of antiepileptic drug used in children with epilepsy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, r\u2009=\u20090.3428), suggesting drug resistant epilepsy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This is the first study in children demonstrating that serum \u03b1-synuclein levels were significantly increased in children with epilepsy and with acquired demyelinating disorders of the CNS and correlated with measures of disease severity. Serum IL-1\u03b2 levels showed significant correlation only with drug resistance in children with epilepsy. Thus, these data support that serum levels of \u03b1-synuclein and IL-1\u03b2 are potential prognostic biomarkers for disease severity in children with epilepsy.<\/jats:p><jats:p>CNS, central nervous system.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12883-020-01662-y","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T09:02:31Z","timestamp":1583744551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Serum \u03b1-synuclein and IL-1\u03b2 are increased and correlated with measures of disease severity in children with epilepsy: potential prognostic biomarkers?"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6845-8745","authenticated-orcid":false,"given":"Jieun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Chan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-3234","authenticated-orcid":false,"given":"Jeon-Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"issue":"Suppl 7","key":"1662_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1528-1167.2011.03121.x","volume":"52","author":"DJ Thurman","year":"2011","unstructured":"Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia. 2011;52(Suppl 7):2\u201326.","journal-title":"Epilepsia"},{"issue":"6","key":"1662_CR2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51(6):1069\u201377.","journal-title":"Epilepsia."},{"key":"1662_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neubiorev.2018.12.008","volume":"96","author":"P Camfield","year":"2019","unstructured":"Camfield P, Camfield C. Regression in children with epilepsy. Neurosci Biobehav Rev. 2019;96:210\u20138.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1662_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pediatrneurol.2012.04.002","volume":"47","author":"A Camacho","year":"2012","unstructured":"Camacho A, Espin JC, Nunez N, Simon R. Levetiracetam-induced reversible autistic regression. Pediatr Neurol. 2012;47(1):65\u20137.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1662_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1542\/peds.2003-1151-L","volume":"114","author":"AT Berg","year":"2004","unstructured":"Berg AT, Smith SN, Frobish D, Beckerman B, Levy SR, Testa FM, et al. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control. Pediatrics. 2004;114(3):645\u201350.","journal-title":"Pediatrics."},{"issue":"1","key":"1662_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2007.04.108","volume":"358","author":"M Nakai","year":"2007","unstructured":"Nakai M, Fujita M, Waragai M, Sugama S, Wei J, Akatsu H, et al. Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage. Biochem Biophys Res Commun. 2007;358(1):104\u201310.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1662_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 2008;5(2):55\u20139.","journal-title":"Neurodegener Dis"},{"issue":"2","key":"1662_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, et al. The precursor protein of non-a beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14(2):467\u201375.","journal-title":"Neuron."},{"issue":"9","key":"1662_CR9","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci. 2000;20(9):3214\u201320.","journal-title":"J Neurosci"},{"issue":"18","key":"1662_CR10","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1097\/WNR.0b013e3280115185","volume":"17","author":"A Adamczyk","year":"2006","unstructured":"Adamczyk A, Strosznajder JB. Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels. Neuroreport. 2006;17(18):1883\u20136.","journal-title":"Neuroreport."},{"issue":"3","key":"1662_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07576.x","volume":"120","author":"ZS Martin","year":"2012","unstructured":"Martin ZS, Neugebauer V, Dineley KT, Kayed R, Zhang W, Reese LC, et al. Alpha-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J Neurochem. 2012;120(3):440\u201352.","journal-title":"J Neurochem"},{"issue":"1","key":"1662_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nan.12303","volume":"42","author":"RA Barker","year":"2016","unstructured":"Barker RA, Williams-Gray CH. Review: the spectrum of clinical features seen with alpha synuclein pathology. Neuropathol Appl Neurobiol. 2016;42(1):6\u201319.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"1662_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, et al. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 2006;20(3):419\u201325.","journal-title":"FASEB J"},{"issue":"5","key":"1662_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, et al. Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol. 2014;128(5):639\u201350.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1662_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1471-4159.2012.07749.x","volume":"122","author":"H Wang","year":"2012","unstructured":"Wang H, Wang K, Xu W, Wang C, Qiu W, Zhong X, et al. Cerebrospinal fluid alpha-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase. J Neurochem. 2012;122(1):19\u201323.","journal-title":"J Neurochem"},{"issue":"5\u20136","key":"1662_CR16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000321342","volume":"32","author":"E Su","year":"2010","unstructured":"Su E, Bell MJ, Wisniewski SR, Adelson PD, Janesko-Feldman KL, Salonia R, et al. Alpha-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia. Dev Neurosci. 2010;32(5\u20136):385\u201395.","journal-title":"Dev Neurosci"},{"issue":"1","key":"1662_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.expneurol.2009.10.009","volume":"225","author":"H Lassmann","year":"2010","unstructured":"Lassmann H. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol. 2010;225(1):2\u20138.","journal-title":"Exp Neurol"},{"issue":"1","key":"1662_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3349\/ymj.2008.49.1.1","volume":"49","author":"J Choi","year":"2008","unstructured":"Choi J, Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med J. 2008;49(1):1\u201318.","journal-title":"Yonsei Med J"},{"issue":"1","key":"1662_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","volume":"7","author":"A Vezzani","year":"2011","unstructured":"Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7(1):31\u201340.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"1662_CR20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S1474-4422(16)00112-5","volume":"15","author":"A Pitkanen","year":"2016","unstructured":"Pitkanen A, Loscher W, Vezzani A, Becker AJ, Simonato M, Lukasiuk K, et al. Advances in the development of biomarkers for epilepsy. Lancet Neurol. 2016;15(8):843\u201356.","journal-title":"Lancet Neurol"},{"issue":"7","key":"1662_CR21","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/epi.12628","volume":"55","author":"ML Diamond","year":"2014","unstructured":"Diamond ML, Ritter AC, Failla MD, Boles JA, Conley YP, Kochanek PM, et al. IL-1beta associations with posttraumatic epilepsy development: a genetics and biomarker cohort study. Epilepsia. 2014;55(7):1109\u201319.","journal-title":"Epilepsia."},{"key":"1662_CR22","first-page":"181","volume":"3","author":"JR Pollard","year":"2012","unstructured":"Pollard JR, Eidelman O, Mueller GP, Dalgard CL, Crino PB, Anderson CT, et al. The TARC\/sICAM5 ratio in patient plasma is a candidate biomarker for drug resistant epilepsy. Front Neurol. 2012;3:181.","journal-title":"Front Neurol"},{"issue":"6","key":"1662_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1750-3639.2010.00414.x","volume":"20","author":"A Li","year":"2010","unstructured":"Li A, Choi YS, Dziema H, Cao R, Cho HY, Jung YJ, et al. Proteomic profiling of the epileptic dentate gyrus. Brain Pathol. 2010;20(6):1077\u201389.","journal-title":"Brain Pathol"},{"key":"1662_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.seizure.2015.02.007","volume":"27","author":"H Rong","year":"2015","unstructured":"Rong H, Jin L, Wei W, Wang X, Xi Z. Alpha-synuclein is a potential biomarker in the serum and CSF of patients with intractable epilepsy. Seizure. 2015;27:6\u20139.","journal-title":"Seizure."},{"issue":"4","key":"1662_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512\u201321.","journal-title":"Epilepsia."},{"issue":"10","key":"1662_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10):1261\u20137.","journal-title":"Mult Scler"},{"issue":"2","key":"1662_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292\u2013302.","journal-title":"Ann Neurol"},{"issue":"2","key":"1662_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology."},{"issue":"1","key":"1662_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12883-018-1196-z","volume":"18","author":"J Zhou","year":"2018","unstructured":"Zhou J, Chen L, Chen B, Huang S, Zeng C, Wu H, et al. Increased serum exosomal miR-134 expression in the acute ischemic stroke patients. BMC Neurol. 2018;18(1):198.","journal-title":"BMC Neurol"},{"key":"1662_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1742-2094-8-135","volume":"8","author":"J Choi","year":"2011","unstructured":"Choi J, Min HJ, Shin JS. Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J Neuroinflammation. 2011;8:135.","journal-title":"J Neuroinflammation"},{"key":"1662_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-2094-6-38","volume":"6","author":"J Choi","year":"2009","unstructured":"Choi J, Nordli DR Jr, Alden TD, DiPatri A Jr, Laux L, Kelley K, et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation. 2009;6:38.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1662_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.20358","volume":"57","author":"C Dube","year":"2005","unstructured":"Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol. 2005;57(1):152\u20135.","journal-title":"Ann Neurol"},{"issue":"12","key":"1662_CR33","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999","volume":"19","author":"A Vezzani","year":"1999","unstructured":"Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci. 1999;19(12):5054\u201365.","journal-title":"J Neurosci"},{"issue":"37","key":"1662_CR34","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.2174\/1381612823666170926113754","volume":"23","author":"G Terrone","year":"2017","unstructured":"Terrone G, Salamone A, Vezzani A. Inflammation and epilepsy: preclinical findings and potential clinical translation. Curr Pharm Des. 2017;23(37):5569\u201376.","journal-title":"Curr Pharm Des"},{"key":"1662_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2018.05.007","volume":"123","author":"A Pitkanen","year":"2019","unstructured":"Pitkanen A, Ekolle Ndode-Ekane X, Lapinlampi N, Puhakka N. Epilepsy biomarkers - toward etiology and pathology specificity. Neurobiol Dis. 2019;123:42\u201358.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"1662_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00726-005-0281-y","volume":"30","author":"JW Yang","year":"2006","unstructured":"Yang JW, Czech T, Felizardo M, Baumgartner C, Lubec G. Aberrant expression of cytoskeleton proteins in hippocampus from patients with mesial temporal lobe epilepsy. Amino Acids. 2006;30(4):477\u201393.","journal-title":"Amino Acids"},{"issue":"12","key":"1662_CR37","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1096\/fj.06-6183com","volume":"20","author":"A Klegeris","year":"2006","unstructured":"Klegeris A, Giasson BI, Zhang H, Maguire J, Pelech S, McGeer PL. Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. FASEB J. 2006;20(12):2000\u20138.","journal-title":"FASEB J"},{"key":"1662_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.aca.2019.07.035","volume":"1082","author":"L Wang","year":"2019","unstructured":"Wang L, Bruce TF, Huang S, Marcus RK. Isolation and quantitation of exosomes isolated from human plasma via hydrophobic interaction chromatography using a polyester, capillary-channeled polymer fiber phase. Anal Chim Acta. 2019;1082:186\u201393.","journal-title":"Anal Chim Acta"},{"key":"1662_CR39","doi-asserted-by":"publisher","first-page":"4503871","DOI":"10.1155\/2018\/4503871","volume":"2018","author":"W Sriwimol","year":"2018","unstructured":"Sriwimol W, Limprasert P. Significant changes in plasma alpha-Synuclein and Beta-Synuclein levels in male children with autism Spectrum disorder. Biomed Res Int. 2018;2018:4503871.","journal-title":"Biomed Res Int"},{"issue":"3","key":"1662_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12291-016-0602-9","volume":"32","author":"I Cetin","year":"2017","unstructured":"Cetin I, Simsek S. A preliminary study on investigation of serum alpha-Synuclein and tau protein levels in children with attention deficit hyperactivity disorder. Indian J Clin Biochem. 2017;32(3):285\u201391.","journal-title":"Indian J Clin Biochem"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01662-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-020-01662-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01662-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:28:49Z","timestamp":1666052929000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01662-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1662"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01662-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All relevant study documentation was reviewed and approved by the responsible Institutional Review Board at the Seoul National University Boramae Medical Center (20080918\/06\u20132008-74\/76). Informed written consent was obtained from the parent of each child, and verbal assent was obtained from each child or adolescent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}